Ocrevus (ocrelizumab) is an infusion therapy approved to treat adults with relapsing forms of MS and primary progressive MS.| Multiple Sclerosis News Today
In MS, slowly expanding lesions were linked to more myelin loss in brain regions of damage and in normal-appearing brain tissue, per a study.| Multiple Sclerosis News Today